Antiseptic and Disinfectant Market Report

Increasing efforts to minimise HAI cases and increase awareness of home and personal hygiene are beneficial to market growth. Rising awareness, particularly in developing countries such as Asia, Africa, Middle East and Latin America, is likely to propel the industry forward swiftly. Furthermore, appropriate reprocessing of medical equipment and endoscopes is required since infection can transmit from patient to patient when these instruments come into close contact to the skin and body. The extensive usage of antiseptic and disinfectant products has aided in the development of microbial resistance, particularly antibiotic cross-resistance. Antiseptics and disinfectants are often used in hospitals and other healthcare institutions for topical and difficult surface applications since they are critical in avoiding nosocomial diseases and infection control procedures. Infections acquired in hospitals can increase the cost, duration of stay and morbidity. According to World Health Organisation (WHO) data updated in 2022, healthcare-associated infections (HAIs) affect hundreds of millions of people globally every year, many of which can be completely avoidable. On average, one out of every ten afflicted individuals would die as a result of a HAI. Each year, 52.3% of patients receiving intensive care unit treatment and over 24% of patients with sepsis related to healthcare die. This is projected to boost antiseptics and disinfectants market growth.

Disinfectant standards set by regulatory agencies are not always satisfied by products on the market. For example, the US Environmental Protection Agency (EPA) requires producers to provide details about chemical composition, toxicity and efficacy, as well as suggested labelling, before registering their products for sale. Disinfectants and sterilant utilised on environmental surfaces are generally regulated by the EPA, but not those used critical or on semi critical medical devices. Such tight laws may have an impact on antiseptic and disinfection revenues across regions. As a result, producers must engage in R&D to achieve these standard formulation standards and provide consumers with safe and excellent products. For instance, in October 2023, 40 packages of Aruba Aloe Hand Sanitizer Gel Alcohol 80% and Aruba Aloe Alcoholada Gel were recalled, by the FDA, because they included alcohol denatured with methanol.

The development of safer and more effective products is boosting the market, credit goes to researchers who are working on antiseptic and disinfection qualities. Formulations that have undergone innovations are more effective against a wider variety of diseases and have fewer negative effects on users and the environment. For instance, in November 2022, researchers from the University of Maryland School of Medicine discovered that two antiseptic solutions, a mixture with an aqueous solution of 10% chlorhexidine and a solution with a 4% aqueous chlorhexidine solution, which is commonly used by surgeons before fracture surgery, was effective in reducing post-surgical infections. Additionally, according to BMJ researchers, hippuric methenamine, an antiseptic drug, was found to be as effective as antibiotics for the treatment of urinary tract infections in women in November 2022, which might further decrease the global burden of antibiotic resistance by stopping the growth of certain bacteria through urine sterilisation.

The rapidly ageing geriatric population and their admission to hospitals, the high adoption of surgical procedures in clinics and the rising prevalence of infectious diseases among the population in the United States drive the market in North America. Furthermore, an increase in the practise of cleaning surgical instruments with disinfectants has been observed in healthcare units in the United States, which is expected to drive the healthcare providers sector of the market in the United States during the forecast period. Further propelling market growth are the growing number of healthcare facilities, stricter sanitation regulations, and growing consumer demand for personal and household hygiene products. Furthermore, there is a strong need for high-quality antiseptic and disinfection solutions in medical settings due to the emphasis on preventing healthcare-associated infections (HAIs), which presents a significant opportunity for suppliers in this market.